| Financial Year |
March 31 2021 |
| Monetary Funds |
1,616,542.05 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
3,107,840.24 |
| Advances to Suppliers |
716,957.46 |
| Other Receivables |
1,437,633,568.23 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
695,558,745.60 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,803,065.80 |
| Total Current Assets |
1,450,877,973.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
135,656,996.90 |
| Fixed Assetes |
17,493,479.28 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,092.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
519,979,568.49 |
| Total Assets |
1,970,857,542.27 |
| Short-Term Loans |
952,200,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
587,763.09 |
| Accounts Received In Advance |
489,394.38 |
| Employee Compensation Payable |
4,265,112.74 |
| Taxes Payable |
445,363.24 |
| Interest Payable |
508,544,848.36 |
| Dividend Payable |
-- |
| Other payables |
2,501,420,195.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
203,415,883.19 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
3,662,823,711.90 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,682,536,062.66 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,682,536,062.66 |
| Total Liabilities |
6,345,359,774.56 |
| Paid-In Capital(Or Share Stock) |
575,732,081.00 |
| Capital Surplus |
987,422,679.57 |
| Surplus Reserve |
54,099,405.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,003,939,356.37 |
| Minority Stockholder's Interest |
12,183,448.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-4,386,685,680.46 |
| Owner's Equity（Stockholder's Equity） |
-4,374,502,232.29 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,970,857,542.27 |
